Literature DB >> 19208301

Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica.

B Killingley1, L E M Lamb, R N Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19208301     DOI： 10.1179/136485909X398177

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  7 in total

1.  A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Authors:  Roshan Ramanathan; Kawsar R Talaat; Daniel P Fedorko; Siddhartha Mahanty; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

2.  Overcoming the Challenge; In Vivo Efficacy of Miltefosine for Chronic Cutaneous Leishmaniasis.

Authors:  Varol Tunalı; Mehmet Harman; İbrahim Çavuş; Cumhur Gündüz; Ahmet Özbilgin; Nevin Turgay
Journal:  Acta Parasitol       Date:  2020-09-29       Impact factor: 1.440

3.  Activity of Cuban Plants Extracts against Leishmania amazonensis.

Authors:  Marley García; Lianet Monzote; Ramón Scull; Pedro Herrera
Journal:  ISRN Pharmacol       Date:  2012-03-15

4.  Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.

Authors:  Ayelet Ollech; Michal Solomon; Amir Horev; Shiran Reiss-Huss; Dan Ben-Amitai; Alex Zvulunov; Rivka Friedland; Vered Atar-Snir; Vered Molho-Pessach; Aviv Barzilai; Shoshana Greenberger
Journal:  Acta Derm Venereol       Date:  2020-10-19       Impact factor: 3.875

5.  Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.

Authors:  Suzette Kämink; Boota Masih; Noor Ali; Aman Ullah; Syed Juma Khan; Shakil Ashraf; Tetyana Pylypenko; Martin P Grobusch; Jena Fernhout; Margriet den Boer; Koert Ritmeijer
Journal:  PLoS Negl Trop Dis       Date:  2021-01-28

6.  Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul.

Authors:  Ahmad Fawad Jebran; Ulrike Schleicher; Reto Steiner; Pia Wentker; Farouq Mahfuz; Hans-Christian Stahl; Faquir Mohammad Amin; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

7.  Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature.

Authors:  Vincent Mosimann; Claudia Blazek; Heini Grob; Matthew Chaney; Andreas Neumayr; Johannes Blum
Journal:  Open Forum Infect Dis       Date:  2016-02-01       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.